The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Nov. 21, 2013
Applicant:

Factor Therapeutics Limited, Darra, AU;

Inventors:

Abhishek Kashyap, Lutwyche, AU;

Gary Keith Shooter, East Ipswich, AU;

David Leavesley, Kenmore Hills, AU;

Brett Hollier, Holland Park, AU;

Adrian Charles Herington, Clayfield, AU;

Zee Upton, Kenmore Hills, AU;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 9/00 (2006.01); C07K 14/72 (2006.01); A61K 38/14 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 9/00 (2013.01); A61K 38/14 (2013.01); A61K 45/06 (2013.01); C07K 14/72 (2013.01); A61K 38/00 (2013.01);
Abstract

Disclosed are methods and agents for modulating proliferation, migration and/or survival of cells. More particularly, the present invention discloses molecules that have any one or more activities selected from: inhibiting binding of vitronectin to at least one vitronectin-binding partner selected from an IGF and IGFBP, inhibiting formation of a complex comprising vitronectin and at least one vitronectin-binding partner selected from an IGF and IGFBP, or inhibiting proliferation or survival of a hyperproliferative cell (e.g., a neoplastic cell or non-neoplastic cell), or inhibiting migration or invasion of a hyperproliferative cell (e.g., a neoplastic cell or a non-neoplastic cell). Additionally, the present invention discloses the use of these molecules in methods and compositions for treating or preventing hyperproliferative cell disorders including neoplastic (e.g., cancers such as epithelial cancers) and non-neoplastic disorders.


Find Patent Forward Citations

Loading…